RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
1.990
+0.060 (3.11%)
Jun 6, 2025, 4:00 PM - Market closed
RedHill Biopharma Employees
RedHill Biopharma had 35 employees as of December 31, 2024. The number of employees decreased by 18 or -33.96% compared to the previous year.
Employees
35
Change (1Y)
-18
Growth (1Y)
-33.96%
Revenue / Employee
$229,800
Profits / Employee
-$236,229
Market Cap
4.56M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
RDHL News
- 24 days ago - RedHill Biopharma Secures Kukbo Asset Freeze Following RedHill's $8.25 Million Plus Legal Fees New York Supreme Court Summary Judgment Win - PRNewsWire
- 5 weeks ago - RedHill-Supported Medscape H. Pylori Educational Program to Launch at Major Gastroenterology Congress - PRNewsWire
- 5 weeks ago - RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107 - PRNewsWire
- 7 weeks ago - RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - PRNewsWire
- 7 weeks ago - RedHill Biopharma's Positive Opaganib Weight Loss & Diabetes Data Published: Signals Potential $100B Market Disruption - PRNewsWire
- 2 months ago - RedHill Biopharma Announces Full-Year 2024 Financial Results and Operational Highlights - PRNewsWire
- 2 months ago - RedHill Biopharma to Submit FDA-Approved Talicia® for UK Marketing Authorisation - PRNewsWire
- 3 months ago - RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn's Disease Program Building on Statistically Significant Positive RHB-104 Phase 3 Results - PRNewsWire